Migraine

Half of people with migraine reported being “extremely dissatisfied” with their ability to control their disease in a survey from the National Headache Foundation, while most patients on a preventive treatment wished for better options.

Microvascular complications from the use of calcitonin gene-related peptide antagonists for migraines are uncommon in patients with underlying Raynaud’s syndrome, according to data published in JAMA Network Open.

Aimovig monotherapy demonstrated sustained efficacy up to 64 weeks among patients with episodic migraine who were unsuccessfully treated with multiple other preventive therapies, according to study findings published in Neurology.

Treatment with Vyepti during a migraine provided earlier freedom from headache pain and most bothersome migraine symptoms — either photophobia, phonophobia or nausea — compared with placebo, according to results from the RELIEF study.

In this video perspective, Jessica Ailani, MD, discusses results from a phase 3 trial of atogepant for the prevention of migraine that were presented during the American Academy of Neurology annual meeting, which is being held virtually.

Women with migraine had an increased risk for hypertension after menopause, but there were no significant differences between migraine with and without aura, according to a longitudinal cohort study launched in 1990.

Migraine diagnoses, treatment and management varied by race and sex among a sample of patients that was “evenly distributed” across the country, according to researchers. 

Children and young adults who experience post-traumatic headache with migraine phenotype may be at increased risk for more significant injury or deleterious pathophysiology after concussion.

Patients with migraine who were given opioids in the ED were more likely to return to the ED in the next 6 months compared with patients who were not prescribed opioids, according to findings from single-center, retrospective cohort study.

Cannabis use ”significantly contributes” to the prevalence of medication overuse headache among patients with chronic migraine, according to study results scheduled for presentation at the American Academy of Neurology Annual Meeting.